REPORT ID 512

United States Non-opioid Analgesic Patch Market Report 2017

Publish Date
04-Dec-17
Pages
98
Format
Electronic (PDF)

In this report, the United States Non-opioid Analgesic Patch market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Non-opioid Analgesic Patch in these regions, from 2012 to 2022 (forecast).

United States Non-opioid Analgesic Patch market competition by top manufacturers/players, with Non-opioid Analgesic Patch sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline Plc
    Pfizer, Inc.
    Teikoku Seiyaku Co., Ltd.
    Mylan N.V.
    Hisamitsu Pharmaceutical Co.,Inc
    Acorda Therapeutics, Inc
    Endo International plc
    Allergan
    Teh Seng Pharmaceutical Mfg
    IBSA Institut Biochimque SA

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Lidocaine Patches
    Diclofenac Patches
    Methyl Salicylate Patches
    Capsaicin Patches
    Ketoprofen Patches
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital Pharmacies
    Online Pharmacies
    Independent Pharmacies & Drug Stores

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Non-opioid Analgesic Patch Market Report 2017
1 Non-opioid Analgesic Patch Overview
    1.1 Product Overview and Scope of Non-opioid Analgesic Patch
    1.2 Classification of Non-opioid Analgesic Patch by Product Category
        1.2.1 United States Non-opioid Analgesic Patch Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Non-opioid Analgesic Patch Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Lidocaine Patches
        1.2.4 Diclofenac Patches
        1.2.5 Methyl Salicylate Patches
        1.2.6 Capsaicin Patches
        1.2.7 Ketoprofen Patches
        1.2.8 Others
    1.3 United States Non-opioid Analgesic Patch Market by Application/End Users
        1.3.1 United States Non-opioid Analgesic Patch Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital Pharmacies
        1.3.3 Online Pharmacies
        1.3.4 Independent Pharmacies & Drug Stores
    1.4 United States Non-opioid Analgesic Patch Market by Region
        1.4.1 United States Non-opioid Analgesic Patch Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Non-opioid Analgesic Patch Status and Prospect (2012-2022)
        1.4.3 Southwest Non-opioid Analgesic Patch Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Non-opioid Analgesic Patch Status and Prospect (2012-2022)
        1.4.5 New England Non-opioid Analgesic Patch Status and Prospect (2012-2022)
        1.4.6 The South Non-opioid Analgesic Patch Status and Prospect (2012-2022)
        1.4.7 The Midwest Non-opioid Analgesic Patch Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Non-opioid Analgesic Patch (2012-2022)
        1.5.1 United States Non-opioid Analgesic Patch Sales and Growth Rate (2012-2022)
        1.5.2 United States Non-opioid Analgesic Patch Revenue and Growth Rate (2012-2022)

2 United States Non-opioid Analgesic Patch Market Competition by Players/Suppliers
    2.1 United States Non-opioid Analgesic Patch Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Non-opioid Analgesic Patch Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Non-opioid Analgesic Patch Average Price by Players/Suppliers (2012-2017)
    2.4 United States Non-opioid Analgesic Patch Market Competitive Situation and Trends
        2.4.1 United States Non-opioid Analgesic Patch Market Concentration Rate
        2.4.2 United States Non-opioid Analgesic Patch Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Non-opioid Analgesic Patch Manufacturing Base Distribution, Sales Area, Product Type

3 United States Non-opioid Analgesic Patch Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Non-opioid Analgesic Patch Sales and Market Share by Region (2012-2017)
    3.2 United States Non-opioid Analgesic Patch Revenue and Market Share by Region (2012-2017)
    3.3 United States Non-opioid Analgesic Patch Price by Region (2012-2017)

4 United States Non-opioid Analgesic Patch Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Non-opioid Analgesic Patch Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Non-opioid Analgesic Patch Revenue and Market Share by Type (2012-2017)
    4.3 United States Non-opioid Analgesic Patch Price by Type (2012-2017)
    4.4 United States Non-opioid Analgesic Patch Sales Growth Rate by Type (2012-2017)

5 United States Non-opioid Analgesic Patch Sales (Volume) by Application (2012-2017)
    5.1 United States Non-opioid Analgesic Patch Sales and Market Share by Application (2012-2017)
    5.2 United States Non-opioid Analgesic Patch Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Non-opioid Analgesic Patch Players/Suppliers Profiles and Sales Data
    6.1 GlaxoSmithKline Plc
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Non-opioid Analgesic Patch Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Pfizer, Inc.
        6.2.2 Non-opioid Analgesic Patch Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Pfizer, Inc. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Teikoku Seiyaku Co., Ltd.
        6.3.2 Non-opioid Analgesic Patch Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Mylan N.V.
        6.4.2 Non-opioid Analgesic Patch Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Mylan N.V. Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Hisamitsu Pharmaceutical Co.,Inc
        6.5.2 Non-opioid Analgesic Patch Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Acorda Therapeutics, Inc
        6.6.2 Non-opioid Analgesic Patch Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Endo International plc
        6.7.2 Non-opioid Analgesic Patch Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Endo International plc Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Allergan
        6.8.2 Non-opioid Analgesic Patch Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Allergan Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Teh Seng Pharmaceutical Mfg
        6.9.2 Non-opioid Analgesic Patch Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 IBSA Institut Biochimque SA
        6.10.2 Non-opioid Analgesic Patch Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Non-opioid Analgesic Patch Manufacturing Cost Analysis
    7.1 Non-opioid Analgesic Patch Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Non-opioid Analgesic Patch

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Non-opioid Analgesic Patch Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Non-opioid Analgesic Patch Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Non-opioid Analgesic Patch Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Non-opioid Analgesic Patch Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Non-opioid Analgesic Patch Sales Volume Forecast by Type (2017-2022)
    11.3 United States Non-opioid Analgesic Patch Sales Volume Forecast by Application (2017-2022)
    11.4 United States Non-opioid Analgesic Patch Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer